A randomised trial of Dolutegravir (DTG)-based antiretroviral therapy vs. standard of care (SOC) in children with HIV infection starting first-line or switching to second-line ART

Project no.: HIV-NAT 229/PENTA20/ODYSSEY (NCT02259127)

This is a randomised trial of dolutegravir (DTG)-based antiretroviral therapy vs. standard of care (SOC) in children with HIV infection starting firstline or switching to second-line ART.